tiprankstipranks
Trending News
More News >

BofA goes to No Rating on Inari Medical after takeover deal

BofA is moving to No Rating on Inari Medical (NARI) after Stryker agreed to acquire Inari for $4.9B, or $80 in cash per share. Given the deal announcement, the firm believes that the stock is no longer trading on fundamentals.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue